Thursday, May 30, 2024 episode artwork

EPISODE · May 30, 2024 · 6 MIN

Thursday, May 30, 2024

from The Gist Healthcare Podcast

Hospital groups join a multi-sector plea to the FTC to delay a new ban on noncompetes. A new study ties weight-loss drug Wegovy to reduced risk for alcohol use disorder. And drugmaker Eli Lilly says it will spend billions of dollars to expand its GLP-1 production capacity. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Hospital groups join a multi-sector plea to the FTC to delay a new ban on noncompetes. A new study ties weight-loss drug Wegovy to reduced risk for alcohol use disorder. And drugmaker Eli Lilly says it will spend billions of dollars to expand its GLP-1 production capacity. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

NOW PLAYING

Thursday, May 30, 2024

0:00 6:57

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Gist Healthcare Podcast?

This episode is 6 minutes long.

When was this The Gist Healthcare Podcast episode published?

This episode was published on May 30, 2024.

What is this episode about?

Hospital groups join a multi-sector plea to the FTC to delay a new ban on noncompetes. A new study ties weight-loss drug Wegovy to reduced risk for alcohol use disorder. And drugmaker Eli Lilly says it will spend billions of dollars to expand its...

Can I download this The Gist Healthcare Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!